The Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment? The Journal addresses each of these perplexing challenges. 

The Journal of Dual Diagnosis includes articles and perspectives from four overarching domains relevant to the field: Psychopharmacology & Neurobiology, Psychotherapy & Psychosocial Issues, Services & Policy, and Clinical Forum. Each issue (although not necessarily each article within an issue) serves to encourage integration of these domains.   The Journal seeks to publish articles relevant to a wide range of individuals interested in dual diagnosis: researchers; physicians; clinicians; trainees and administrators. High-quality empirical research, brief reports, timely reviews, thought-provoking editorials, and on-going discussions of clinical issues will be considered for publication, all with the aim of developing a better understanding of the basis of and optimal treatment for co-occurring psychiatric and substance use disorders.